Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Omega Diagnostics Group PLC    ODX   GB00B1VCP282

OMEGA DIAGNOSTICS GROUP PLC

(ODX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
01/20/2021 01/21/2021 01/22/2021 01/25/2021 01/26/2021 Date
53(c) 61(c) 70(c) 78(c) 75 Last
1 818 460 3 156 318 9 717 820 6 559 411 6 495 227 Volume
-0.93% +15.09% +14.75% +11.43% -3.85% Change
More quotes
Financials
Sales 2021 12,6 M 17,2 M 17,2 M
Net income 2021 0,50 M 0,68 M 0,68 M
Net cash position 2021 7,10 M 9,67 M 9,67 M
P/E ratio 2021 260x
Yield 2021 -
Sales 2022
Net income 2022
Net Debt 2022
P/E ratio 2022
Yield 2022
Capitalization 140 M 192 M 191 M
EV / Sales 2021 10,6x
EV / Sales 2022
Nbr of Employees 152
Free-Float 86,4%
More Financials
Company
Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme... 
More about the company
All news about OMEGA DIAGNOSTICS GROUP PLC
2020Omega Diagnostics Gains 9% on Smaller Fiscal H1 Loss
MT
2020Omega Diagnostics' Partner Abingdon Health Granted US FDA Approval to Distrib..
MT
2020MARKET CHATTER : Abingdon Health Plans $26 Million London IPO
MT
2020Omega Diagnostics Rejects Media Report on Rapid Test Performance as Shares Si..
MT
2020Omega Diagnostics Gets Chinese Regulatory Approval For Food Detective Test
MT
2020OMEGA DIAGNOSTICS : COVIS-19 ELISA - Approval for sale in India
PU
2020OMEGA DIAGNOSTICS GROUP PLC : RIGHTS ISSUE: 1 new share @ 0.4 GBP for 20 existin..
FA
2020OMEGA DIAGNOSTICS : Fundraising to raise gross proceeds of up to £11m
PU
2020Health Care Up, But Lags Broad Market, Amid Cyclical Bets -- Health Care Roun..
DJ
2020OMEGA DIAGNOSTICS : Material Transfer Agreement with Mologic on COVID-19
PU
2019OMEGA DIAGNOSTICS : Interim Results - Year Ended 30 September 2019
PU
2019OMEGA DIAGNOSTICS : Investor Briefing
PU
2019OMEGA DIAGNOSTICS : Investor results briefing
PU
2019OMEGA DIAGNOSTICS : VISITECT CD4 Advanced Disease order
PU
2019OMEGA DIAGNOSTICS : CD4 Advanced Disease CE-Mark
PU
More news
News in other languages on OMEGA DIAGNOSTICS GROUP PLC

- No features available -

More news
Chart OMEGA DIAGNOSTICS GROUP PLC
Duration : Period :
Omega Diagnostics Group PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OMEGA DIAGNOSTICS GROUP PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Average target price
Last Close Price 0,78 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers and Directors
NameTitle
Colin King CEO, Chief Operating Officer & Director
Bill E. Rhodes Independent Non-Executive Chairman
Kieron Antony Harbinson CFO, Secretary & Executive Director
Jag Grewal Executive Director & Commercial Director
Jeremy Howard Millard Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
OMEGA DIAGNOSTICS GROUP PLC20.93%192
10X GENOMICS, INC.29.41%19 719
BIOMÉRIEUX10.83%18 351
DIASORIN S.P.A.5.64%11 900
NATERA, INC.19.57%10 159
AUTOBIO DIAGNOSTICS CO., LTD.-0.72%10 031